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CC BY-NC-ND license (http://creativeAbstract Objective: To investigate the biological basis of “depression with liver-qi stagna-
tion and spleen deficiency syndrome”.
Methods: A digital gene expression profiling method was conducted to explore global changes
in the mRNA transcriptome in a rat model of depression with liver-qi stagnation and spleen
deficiency syndrome. Real-time quantitative polymerase chain reaction (q-PCR) was per-
formed to verify the five genes most interest based on the Kyoto Encyclopedia of Genes and
Genome (KEGG) analysis. Sini San, which disperses stagnated liver qi and strengthens the
spleen, was administered to the model rats to observe whether it could reverse these genetic
changes in the liver.
Results: Forty-six differentially expressed genes were identified. Three of the five genes of
most interestdHnf4a, Hnf4g and Cyp1a1dbased on KEGG analysis, were confirmed by real-
time q-PCR. Sini San reduced the gene expression changes of Hnf4a, Hnf4g and Cyp1a1 in
the rat model.
Conclusions: Hnf4a, Hnf4g and Cyp1a1 are involved in “depression with liver-qi stagnation and
spleen deficiency syndrome”. These findings indicate that depressed rats with liver-qi stagna-
tion and spleen deficiency syndrome are at risk of liver diseases. Furthermore, our results will
inform exploration of the etiology of depression and help in the development of effective ther-
apeutic strategies.6.com (W. Wang).
f Beijing University of Chinese Medicine.
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Depression is a complex psychiatric disorder characterized
by anhedonia and feelings of sadness.1 According to the
World Health Organization (WHO), depression is expected
to be the second leading cause of disability after heart
disease by 2020.2 Although depression has been intensively
studied, its etiology and effective therapeutic strategies
are still elusive. In China, traditional Chinese medicine
(TCM) has been widely used in the treatment of depression
and often provides good therapeutic effect. According to
TCM theory, dysfunction of the liver za`ng is the cause of
depression and the most common syndrome in depression is
“liver-qi stagnation and spleen deficiency”.3 Sini San,
which disperses stagnated liver qi and strengthens the
spleen, is a prescription that has proven beneficial for
curing depression.4,5 Hence, study of the biological basis of
“depression with liver-qi stagnation and spleen deficiency”
syndrome is necessary to understand the etiology of the
condition and to develop effective therapeutic strategies.
TCM posits that the response of the body to stress is
associated with the function of liver za`ng.6 Hence, chronic
unpredictable mild stress (CUMS), which mimics daily stress
levels in humans, has been commonly used in researching
liver za`ng dysfunction. Exposed to stress, different tissues
and organs have to interact extensively to adapt to envi-
ronmental challenges. Among these organs, the liver, as
defined by its anatomy, is of particular interest given its vital
roles in maintaining homeostasis and health as well as
regulating nutrient utilization and overall metabolism.7 Be-
sides, in TCM theory, the function of the liver, as defined by
modern anatomy, is an important component of liver za`ng.8
Hence, we speculate that changes in the liver must be an
important part of the biological basis of “depression with
liver-qi stagnation and spleen deficiency syndrome”.
Based on the above speculation, we first established a
reliable rat model of depression with liver-qi stagnation and
spleen deficiency syndrome, according to the method estab-
lished in our previous studies.9 Second, digital gene expres-
sion profiling (DGE), which can analyze global changes in the
mRNA transcriptome, was conducted to analyze genetic
changes in the liver. Finally, the classic prescription, Sini San,
composed of Chinese thorowax root (Bupleurum chinense
DC), immature orange fruit (Citrus aurantium L), red peony
root (Paeonia lactiflora Pall) and licorice (Glycyrrhiza ura-
lensis Fisch), was administered to the model rats to observe
whether it could reverse the genetic changes in the liver.Materials and methods
Animals
One hundred and ten male SpragueeDawley rats (weighing
approximately 200  20 g) (Animal license No: SCXK Beijing2012-0001) were purchased from Beijing Vitalriver Labora-
tory Animal Research Center, China. All rats were raised in
a common animal room with a temperature of 18e24C and
humidity of 40e60%. The rats were given free access to
conventional feed and water. The experimental protocols
were approved by the Beijing University of Chinese Medi-
cine Institutional Animal Care and Use Committee (Ethics
number: 2013BZHYLL1001B). All efforts were made to
minimize animal suffering.Grouping
After adaptive feeding for 2 weeks, the rats were randomly
divided into two groups according to body weight: CUMS
group (nZ 89) and control group (nZ 21). Rats in the CUMS
group were housed in isolation, while the other rats were
housed in groups of four to five. After 6 weeks, the CUMS
rats were considered the depression model with liver-qi
stagnation and spleen deficiency syndrome and were
randomly divided into three groups according to behavioral
tests: (1) model group (M group)d21 rats receiving distilled
water and subjected to the CUMS procedure; (2) Sini
San þ CUMS group (S group)d14 rats receiving Sini San
dissolved in distilled water and then subjected to the CUMS
procedure; (3) fluoxetine þ CUMS group (F group)d18 rats
receiving fluoxetine in distilled water and then subjected to
the CUMS procedure. Rats in the control group (C group)
remained the same.Sini San and fluoxetine administration
Sini San is composed of Chinese thorowax root (Bupleurum
chinense DC.), immature orange fruit (C. aurantium L), red
peony root (P. lactiflora Pall) and licorice (G. uralensis
Fisch) in a ratio of 1:1:1:1. The herbs were purchased from
Beijing Tong Ren Tang Group (Beijing, China), and identified
according to the Pharmacopoeia of the People’s Republic of
China (2010 edition), by the ChinaeJapan Friendship Hos-
pital Pharmacy in Beijing. Sini San granules were prepared
by Beijing Kang Ren Tang Pharmaceutical (Beijing, China).
The granules were dissolved in distilled water to make a
Sini San suspension, containing raw materials at a concen-
tration of 0.25 g/mL. Sini San dosage for human adults is
24 g/day (assuming a body weight of 60 kg for an adult
human). This dosage is 2.5 g/kg/day, calculated using a
human to rat dose conversion coefficient.10 Fluoxetine was
purchased as 20 mg capsules from Lilai Suzhou Pharma-
ceutical (Jiangsu, China) and was dissolved in distilled
water at a concentration of 0.2 mg/mL. Prior to daily CUMS
exposure, rats in the S group were gavaged with Sini San
suspension (1 mL/100 g), rats in the F group were gavaged
with fluoxetine suspension (1 mL/100 g) and rats in the M
and C groups were gavaged with distilled water (1 mL/
100 g).
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procedures
According to previous CUMS rat models, the following
stimulations were applied to the experimental animals and
included: food deprivation for 24 h; water deprivation for
24 h; wet housing overnight; forced swimming at 4C for
5 min; restraint for 2.5 h; overnight illumination; cage tilt
(45) for 12 h; tail clamping, in which a hemostatic clamp
was placed on the tail near the base for 1.5 min, with
enough pressure to cause the rat to vocalize; 36 sessions of
electrical stimulation that was administered as inescapable
foot shock in a chamber at a 1.5 mA intensity consisting of
30 shocks in 1 min, with an interval of 30 s between ses-
sions. The rats were exposed to a random selection of two
stressors from the above stimulations per day, with no
repeat of the same type in continuous days, which guar-
anteed that the animal would face unpredictable
stimulation.
Methods for identifying the rat model of depression
with liver-qi stagnation and spleen deficiency
syndrome
According to the methods established in our previous
study,9 we assigned symptoms, which are used to discrim-
inate the disease and syndrome in the clinic,11 to macro-
scopic visible features in the rats. The specific assignments
were as follows:
Rats exhibiting three main macroscopic visible features,
or the first two main ones with the secondary macroscopic
visible feature were diagnosed as depressed rats with liver-
qi stagnation and spleen deficiency syndrome.
Related behavioral tests
Open field test (OFT)
The OFT was performed to assess spontaneous exploratory
activity. The open field arena was a square
100 cm  100 cm black floor divided by eight lines into 25
equal squares, surrounded by a 35 cm high wall. A digital
camera was placed 2 m above the open field to capture theCriteria for
clinical discrimination
Criteria for
rat discrimination
Main symptoms Main macroscopic visible features
Feeling depressed Reduced sucrose preference
and locomotor activity
Distending pain in
hypochondrium or
stomach ache
React violently against grabbing
Poor appetite Slow increase of body weight
Loose stools Loose stools
Secondary symptom Secondary macroscopic
visible feature
Borborygmus and flatus The number of defecations
increase when the tail was pulledwhole field. During the OFT, rats were placed in the center
of the field and recorded using a small animal behavior
recorder for 3 min. Rearings were counted manually during
the recording. An animal behavior analysis system was used
to analyze the total movement distance during the 3 min.
Sucrose preference test (SPT)
The SPT was used to evaluate potential anhedonia in the
experimental animals. Rats were trained for the SPT by
providing a continuous choice of two bottles, which contain
2% sucrose, for 24 h. Afterward, one of the bottles was
replaced with water for 24 h. During this 24-h period, the
bottles were switched after 12 h to control for any side
bias. Following this adaptation procedure, the rats were
deprived of water and food for 12 h. The SPTwas conducted
at 9:00 a.m. The rats were housed in individual cages and
given free access to the two bottles of water and sucrose,
which were weighed in advance. After 4 h, the weight of
both the consumed sucrose solution and water was recor-
ded. The sucrose preference was calculated as
sucrose preferenceð%Þ
Z
sucrose consumptionðgÞ
sucrose consumptionðgÞ þwater consumptionðgÞ  100%:
Forced swimming test (FST)
The FST was conducted to evaluate the degree of despair.
An experimental animal was placed in a round glass
container with a diameter of 25 cm and a height of 45 cm.
The water was filled to a height of 30 cm with a tempera-
ture of 25  5C. The FST paradigm included two phases: an
initial 15 min pre-test followed by a 5 min test 24 h later.
The duration of animal immobility in the 5 min was recor-
ded. The criteria for animal immobility recognition were:
(1) cessation of struggling; (2) upright floating posture; and
(3) occasional limb movement to maintain the head above
the water level with no observed body movement.
Sampling
Before noon of the second day after completion of the 8-
week experiment, the rats were sacrificed by decapitation.
Their livers were immediately removed and frozen in liquid
nitrogen, then stored at 80C until use.
Total RNA extraction, library construction, and
RNA-Seq
Six samples from the C group and four samples from the M
group were randomly selected for DGE analysis. Total RNA
was extracted from the samples using TRIzol reagent
(Invitrogen, Carlsbad, CA, USA) according to the instruction
manual. RNA concentration and purity were measured using
a NanoDrop 2000 Spectrophotometer (Thermo Fisher Sci-
entific, Wilmington, DE, USA). RNA integrity was assessed
using the RNA Nano 6000 Assay Kit of the Agilent Bio-
analyzer 2100 System (Agilent Technologies, CA, USA).
High-quality RNA was sent to Biomarker Technologies Cor-
poration (Beijing, China) for cDNA library construction and
sequencing. mRNA was purified by the interaction of poly
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libraries were generated using the NEBNext Ultra RNA Li-
brary Prep Kit from Illumina (New England Biolabs, Ipswich,
MA, USA) with multiplexing primers, according to the
manufacturer’s protocol. The cDNA library was constructed
according to non-stranded library preparation with average
inserts of 200 bp (150e250 bp). cDNAs were purified using
AMPure XP Beads (Beckman Coulter, CA, USA). The short
cDNA fragments were subjected to end repair and adapter
ligation. Then, suitable fragments were selected using
Agencourt AMPure XP beads (Beckman Coulter) and
enriched by polymerase chain reaction (PCR) amplification.
Sequencing was performed via a paired-end 125 cycle rapid
run on the Illumina HiSeq2500 platform.
Transcriptome data analysis and identification of
differential gene expression
The raw data containing adapter sequences, reads with low
quality sequences and unknown nucleotides were filtered
out to obtain clean reads. All clean reads were then map-
ped to the Rattus norvegicus genome (rn5) using TopHat2.12
Gene expression levels were estimated using FPKM values
(fragments per kilobase of exon per million fragments
mapped) using Cufflinks.13
DESeq14 and Q-values were employed to evaluate dif-
ferential gene expression between C and M groups. mRNA
abundance differences between samples were calculated
based on the ratio of the FPKM values. The false discovery
rate (FDR) control method was used to identify the
threshold of the P-value in multiple tests to compute the
significance of the differences. Only genes with an absolute
value of log2 ratio 2 and FDR significance score <0.01
were used for subsequent analysis.
Bioinformatic analysis of the differential gene
expression profile
Genes were compared using BLASTX15 against two protein
databases, the non-redundant protein (Nr) database and
the Kyoto Encyclopedia of Genes and Genome (KEGG)
pathway database with a cutoff E-value of 105. Genes
were retrieved based on the best BLAST hit (highest score)
along with their protein functional annotation.
An enrichment factor based on KEGG16 (http://www.
genome.jp/kegg) was used to identify markedly enriched
pathways in differentially expressed genes compared with
the whole genome background. The formula to calculate
the enrichment factor is:
Enrichment factorZ
n=N
m=M
where N is the number of all genes with KEGG annotation, n
is the number of differentially expressed genes (DEGs) with
KEGG annotation, M is the number of all genes annotated to
specific pathways, and m is the number of DEGs annotated
to specific pathways. P values were calculated by the Fisher
exact test and corrected by the Bonferroni method to
obtain Q values.Quantitative real-time PCR (qRT-PCR) analysis
qRT-PCR was performed to verify the up-regulation of
Cyp1a1, Cyp1a2 and Cyp7b1 expression and the down-
regulation of Hnf4a and Hnf4g expression. PCR primer se-
quences are shown in Table 5. Six samples from each of the
four groups were randomly selected for verification of the
possible effects of Sini San and fluoxetine on the liver.
Primers were synthesized by Sangon Biotech Company. qRT-
PCR was performed using SYBR Green Real-time PCR Master
Mix on a StepOne Plus Realtime PCR system (Applied Bio-
systems, CA, USA). PCR reactions consisted of 1 mL PCR
reaction system, 1 mL cDNA template, 1 mL upstream
primer, 1 mL downstream primer, and 5 mL SYBR Green I.
The reaction conditions were as follows: denaturation for
10 min at 95C; 40 cycles of 95C for 15 s, 58C for 30 s, and
72C for 30 s; reading plate and solubility curve were per-
formed at 60e95C. The reaction was terminated, and the
temperature was reduced to 4C. The 2OOCT method
was used to determine relative mRNA levels.16
Behavior and PCR data analysis
SPSS17.0 (SPSSv.17.0 forWindows;SPSS Inc.,Chicago, IL,USA)
was used to analyze the data. A ShapiroeWilk testwas used to
examine the normality of the data. If the data fitted a normal
distribution, a one-way analysis of variance was used to
compare the four groups. Foreach comparisonof two selected
groups, a least significant differencepost hoc testwas used for
datawith ahomogeneity of variance. If the data did nothave a
normal distribution with a homogeneity of variance, a Man-
neWhitney U testwas used to compare two selected groups of
the four groups. A correlation analysis between the behavioral
test results andgeneexpression levels verifiedbyqRT-PCRwas
also performed. All data are expressed as the mean (SD). A
value of P < .05 was considered significant.
Results
Identification of depressed rats with liver
stagnation and spleen deficiency syndrome
After 6 weeks of the CUMS regimen, two rats had died
following the forced swimming stress procedure, twenty
rats were identified as not depressed according to the OFT
and SPT, and fourteen rats were identified as depressed but
not with liver stagnation and spleen deficiency syndrome.
Among the 89 rats exposed to 6 weeks of CUMS, 53 rats
(60%) were identified as depressed with liver stagnation and
spleen deficiency syndrome. These 53 rats were again
randomly divided into three groups (M, S and F groups) and
continued to be exposed to CUMS for another 2 weeks.
After 8 weeks of CUMS, all rats in the M group, seven rats in
the S group and nine rats in the F group remained with liver
stagnation and spleen deficiency syndrome.
Behavioral tests
As shown in Tables 1e3, compared with rats in C group, rats
in M and S groups have significant differences in the OFT,
Table 1 Effects of drug administration on the OFT.
Rearings Total movement distance
Before treatment After treatment Before treatment After treatment
C group 8.30 (3.84) 6.81 (4.51) 1603.00 (463.89) 1184.60 (472.69)
M group 2.06 (0.90)* 0.88 (1.32)* 1043.81 (569.89)* 474.86 (358.40)*
S group 3.54 (2.73)* 4.08 (3.85)# 875.01 (476.41)* 717.57 (421.90)*
f group 2.94 (2.48)* 3.22 (3.22) *# 734.08 (449.84)* 441.73 (300.08)*
*P  .05 in comparison to C group, #P  .05 in comparison to M group; values are means (SD) (unit: s) (N Z 21, 17, 13,18).
Table 2 Effects of drug administration on the SPT.
N Percent sucrose preference in SPT
Before treatment After treatment
C group 21 0.71 (0.17) 0.79 (0.14)
M group 21 0.46 (0.20)* 0.50 (0.20)*
S group 14 0.44 (0.23)* 0.57 (0.23)*
F group 17 0.40 (0.20)* 0.55 (0.21)*
*P.05 in comparison to C group, values aremeans (SD) (unit: %).
Table 3 Effects of drug administration on the FST.
N Immobility time in FST
Before treatment After treatment
C group 21 8.00 (6.84) 12.90 (11.08)
M group 19 35.75 (33.88)* 60.53 (57.95)*
S group 13 29.86 (29.30)* 38.08 (24.98)*
F group 16 48.33 (53.53)* 73.00 (56.47)*
*P.05 in comparison to C group; values aremeans (SD) (unit: s).
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there were no significant differences between the M, S and
F groups in the three behavior tests before drug adminis-
tration. After a 2-week treatment, compared with the S
group, both Sini San and fluoxetine administration signifi-
cantly increased the number of rearings (Table 1, M vs. S:
P Z .012; M vs. F P Z .005). In the OFT and SPT, Sini San
and fluoxetine administration tended to increase total
movement distance (Table 1) and sucrose preference
(Table 2), although these differences were not significant
compared with the M group. In the FST (Table 3), Sini San
administration tended to increase the immobility time,
while fluoxetine administration did not have a significant
effect compared with the M group.
Detection of differentially expressed genes
Compared with the control group, 46 differentially
expressed genes were identified in the M group, of which 12
were up-regulated and 34 were down-regulated.
KEGG pathways associated with differentially
expressed genes
To further explore the interactions and biological functions
of differentially expressed genes, they were searchedagainst the reference pathways in KEGG. A total of 26 genes
were annotated and assigned to 36 KEGG pathways. As
shown in Fig. 1, the pathways were mainly involved with
environmental information processing, human diseases,
cellular process, metabolism, genetic information pro-
cessing and organismal systems. Among the 36 pathways,
the six most reliable pathways were identified by enrich-
ment factors and Q values as shown in Table 4. These six
pathways are mainly involved with five up-regulated genes
(Cyp1a1, Cyp1a2, Cyp7b1, Map2k6 and Slc1a2) and two
down-regulated genes (Hnf4a and Hnf4g).
The y-axis indicates names of pathways, and the x-axis
indicates the number of genes and the proportion of the
total annotated genes.Real-time qPCR
Based on the KEGG analysis, five genes (Table 5) were
chosen for validation by quantitative real-time qPCR. The
samples from the C and M groups were different from those
used in the DGE analysis. Additionally, six random samples
from both S and F groups were selected for real-time qPCR
analysis, to investigate the effects of Sini San and fluoxe-
tine administration on changes in the expression of these
genes in the liver. As shown in Table 6, the expression levels
of Hnf4a and Hnf4g were significantly reduced in the M
group compared with the C group (Hnf4a: PZ .037; Hnf4g:
P Z .000), which was consistent with the DGE results. Sini
San and fluoxetine administration significantly increased
the expression levels of Hnf4a and Hnf4g compared with
the M group [Hnf4a: P (S vs. M) Z 0.045, P (F vs.
M) Z 0.016; Hnf4g: P (S vs. M) Z 0.039, P (F vs.
M) Z 0.001]. As shown in Table 7, the expression level of
Cyp1a1 was significantly increased in the M group compared
with the C group (PZ .006), which was consistent with the
DGE results. Cyp1a2 and Cyp7b1 showed a tendency of
increased expression in the M group compared with the C
group but without significance.Correlations between behavior and genes
The expression of three genes, Hnf4a, Hnf4g and Cyp1a1,
was verified by qPCR. We analyzed the correlations be-
tween the behavioral test results and the expression levels
of the three genes in the liver. The only significant corre-
lation was between the number of rearings in the OFT and
the expression level of Hnf4g in the liver (r Z 0.472,
P Z .041).
Figure 1 KEGG annotation and classification of DEGs.
Table 4 KEGG enrichment of DEGs (the six most markedly enriched pathways).
Pathway DEGs Enrichment factor Q value
Maturity onset diabetes of the young Hnf4a, Hnf4g 0.03 5.3446e-02
Tryptophan metabolism Cyp1a1, Cyp1a2 0.06 1.9532e-01
Steroid hormone biosynthesis Cyp1a1, Cyp7b1 0.06 2.1088e-01
Retinol metabolism Cyp1a1, Cyp1a2 0.07 3.2530e-01
Amyotrophic lateral sclerosis (ALS) Map2k6, Slc1a2 0.07 3.3503e-01
Metabolism of xenobiotics by cytochrome P450 Cyp1a1, Cyp1a2 0.09 4.8476e-01
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In TCM theory, a syndrome is the pathological summary of
the location, cause, nature and condition of a disease at a
certain stage, and this is the core of TCM treatment.
Studies to understand the biological basis of a syndrome areimperative for the popularization and application of TCM
theory in modern medicine.
Establishment of a reliable rat model of disease com-
bined with the corresponding syndrome is important for
the investigation of the biological basis of a syndrome.
Modern researchers of TCM deem that the body’s response
Table 6 Expression levels of Hnf4a and Hnf4g in each
group.
Hnf4a Hnf4g
C group 7.37 (6.04) 3.01 (1.64)
M group 1.24 (0.91)* 0.00 (0.87)*
S group 2.69 (1.35)# 1.50 (1.30)*#
F group 3.12 (0.98)# 2.55 (0.45)#
*P  .05 in comparison to C group, #P  .05 in comparison to M
group; values are means (SD).
Table 7 Expression levels of Cyp1a1, Cyp1a2 and Cyp7b1
in each group.
Cyp1a1 Cyp1a2 Cyp7b1
C group 0.31 (0.15) 1.38 (0.40) 0.76 (0.43)
M group 1.24 (0.93)* 1.57 (1.33) 1.13 (0.53)
S group 0.42 (0.36) 3.64 (1.91) 1.03 (0.46)
F group 1.02 (0.76) 1.14 (1.12) 0.94 (0.86)
*P  .05 in comparison to C group.
Table 5 Primers used for validation analysis.
Gene ID Gene
name
Primer
ENSRNOG-
00000008895
Hnf4a F:GGGAGGAGACGAGAGAGGAT
R:GGCGTGAAGTCCGTGATTAG
ENSRNOG-
00000008971
Hnf4g F:GTCGCCAGTGTGTTGTTGAC
R:CGTGCTTCTTCTTGTGCTGA
ENSRNOG-
00000019500
Cyp1a1 F:GACCACGATGACCAAGAGC
R:GGGAGGTAACGGAGGATAGG
ENSRNOG
00000016173
Cyp1a2 F:GTGGAATCGGTGGCTAATGT
R:AGTCCTTGCTGCTCTTCACG
ENSRNOG
00000009730
Cyp7b1 F:TTGAGGTTCTGAGGTTGTGC
R:TGGGTCATTGTGTATCATTGG
156 J. Li et al.to stress is associated with the function of liver za`ng.
Hence, a rat model of depression, which uses a regimen of
CUMS, has been commonly used to investigate the bio-
logical basis of liver za`ng dysfunction. We have previously
demonstrated that, according to the method of trans-
forming clinical symptoms into equivalent macroscopic
visible features in rats, there were depression symptoms
with liver-qi stagnation and spleen deficiency syndrome in
most rats tested after 6e8 weeks of CUMS.9 In the present
study, by the same method, 60% of all rats tested were
identified as depressed with liver-qi stagnation and spleen
deficiency syndrome after 6 weeks of CUMS, which was
consistent with our previous study. Based on this reliable
rat model, a DEG method was used to explore differential
gene expression in the liver. As a result, 46 DEGs were
identified based on stringent screening criteria (log2 ratio
2 and an FDR significance score <0.01), demonstrating
that the liver was involved in the dysfunction of liver
za`ng. Among the 46 DEGs, expression of the five most
important genes as determined by KEGG analysis wasverified by real-time qPCR. Expression of three of the five
genes was verified, while the other two had the same
changing trend of expression with that identified by DEG.
This indicated that the five genes, especially the three
verified genes, are involved in the biological basis of
“depression with liver-qi stagnation with spleen deficiency
syndrome”.
Expression levels of Hnf4a and Hnf4g were significantly
decreased in the M group. Hnf4a is a member of the nu-
clear receptor superfamily, which is highly expressed in
the liver, with lower levels in the kidney, intestine and
pancreatic b cells.17 Hnf4a regulates important hepatic
functions, such as glycolysis, gluconeogenesis, urea gene-
sis, fatty acid metabolism, bile acid synthesis, drug
metabolism, apolipoprotein synthesis, and blood coagula-
tion, by regulating the transcription of many of the genes
involved in each of these functions.18 Because of its
involvement in a wide array of hepatic functions, Hnf4a is
known as the master regulator of hepatic function.19
Furthermore, Hnf4a alterations in the brain have been
associated with depression pathogenesis.20 But an associ-
ation between Hnf4a alterations in the liver and depres-
sion pathogenesis has not been established. Nevertheless,
there is a report demonstrating up-regulation of Hnf4a in
the liver following four consecutive psychological stress
procedures,21 which is contrary to our results. Hence, we
speculate that the level of Hnf4a in the liver may first be
up-regulated and then down-regulated with prolonged
stress time. There are a variety of studies providing evi-
dence that the down-regulation of Hnf4a is associated
with the pathogenesis of hepatic fibrosis22 and cirrhosis,23
nonalcoholic fatty liver disease,24 and hepatocellular car-
cinoma development.25 As most of these diseases demon-
strate symptoms of distending pain in the hypochondrium,
poor appetite and fatigue, the syndrome of liver-qi stag-
nation and spleen deficiency was deemed as the most
common syndrome in these chronic liver diseases.26 In TCM
theory, different diseases with the same syndrome must
share the same pathological basis. In the present study,
the change in Hnf4a expression found in the depression
model indicated that Hnf4a in the liver is involved liver-qi
stagnation and spleen deficiency syndrome, and also in-
dicates that patients with depression and liver-qi stagna-
tion and spleen deficiency syndrome are at risk of liver
disease. Hnf4g is a newly discovered gene homologous to
Hnf4a,27 that is expressed in the intestine, liver, pancre-
atic islets, and brain.28 Compared with Hnf4a, the physi-
ological function of Hnf4g is less well understood. There
were several studies suggesting that Hnf4g is associated
with inflammation29 and cancer30 in the intestine and
stomach. But the function of Hnf4g in the liver has not
been reported. However, Hnf4g knockout mice show
depressive behavior that could be reversed when admin-
istered 3a,5a-tetrahydroprogesterone (3a5a-THP). The
authors of this finding speculated that inactivation of
Hnf4g might decrease transcription of 3a-hydroxysteroid
dehydrogenase (3a-HSD) resulting in a decreased reduction
of 5a-dihydroprogesterone (5a-DHP) to 3a5a-THP, which
might cause signs of depression. Notably, in the present
study, we found that the expression level of Hnf4g in the
liver was down-regulated and was positively correlated
with the number of rearings in the OFT, suggesting a
Biological basis of “depression with liver-qi stagnation and spleen deficiency syndrome” 157possible relationship between depressive behavior and
Hnf4g in the liver. But whether Hnf4g is a cause of
depression pathogenesis needs further research.
There is a growing body of evidence suggesting that
stress can modify the P450 cytochromes (Cyps) in the liv-
er.31e34 Two primary effectors of the stress response sys-
tem, namely glucocorticoids and adrenergic pathways are
suggested to be the main cause of changes to Cyps in the
liver via several signaling pathways.35e37 In the present
study, we confirmed that cytochrome P4501A1 (Cyp1a1)
expression in the liver was up-regulated in the stress-
induced depression with liver-qi stagnation and spleen
deficiency syndrome model. Cyp1a1 is a key enzyme in the
biotransformation of environmental toxicants and carcino-
gens, such as aromatic amines and polycyclic aromatic
hydrocarbons. Induction and elevated activity of Cyp1a1
has been associated with toxicity and increased cancer risk
in subjects exposed to tobacco smoke or other environ-
mental pollutants, including these componds.32 Cyp1a2,
which shares the main functions of Cyp1a1,35 also demon-
strated increased expression levels. Hence, combined with
the Hnf4a results, the model of depression with liver-qi
stagnation and spleen deficiency syndrome may also be at
risk of cancer. In addition to the Cyp1a subfamily, the
present study demonstrated a tendency of increased
Cyp7b1 expression. As Cyp7b1 has a close relationship with
bile acid synthesis,38 it may be responsible for the syn-
drome of spleen deficiency.
Besides investigating alterations in the liver in the rat
model, we also evaluated the effect of Sini San and fluox-
etine treatment. Both Sini San and fluoxetine treatment
could improve depression-related behaviors, although the
effect was not remarkable. This result may be due to the
fact that the 2-week drug therapy was relatively short. The
depression behavior phenotypes may be improved signifi-
cantly with a prolonged treatment time. Notably, Sini San
administration significantly reduced the alterations in Hnf4
subtype expression and had a tendency to reduce changes
to Cyp1a1 expression. In TCM theory, Sini San is a classic
prescription that has the function of dispersing stagnated
liver qi and strengthening the spleen. These results further
confirmed that Hnf4a, Hnf4g, and Cyp1a1 are involved in
the biological basis of liver-qi stagnation and spleen defi-
ciency syndrome.
In conclusion, using DEG technology to investigate global
changes in the mRNA transcriptome and q-PCR to verify the
highest DEGs, and by evaluating the effect of Sini San on
theses DEGs, we have demonstrated three genes in the liver
that are involved in depression with liver-qi stagnation and
spleen deficiency syndrome. These findings suggest a high
risk of liver disease in this model. However, there are some
limitations in our study. First, we only verified five DEGs
based on KEGG analysis. Further studies to verify the other
DEGs are warranted. Second, few studies have been per-
formed to investigate alterations in the liver in depression
models; therefore, further research is needed to investi-
gate the mechanism of these changes in gene expression.
This will help in the development of more targeted rem-
edies for depression. Despite these limitations, we believe
that our study has demonstrated a group of genes that are
involved in depression combined with liver-qi stagnation
and spleen deficiency syndrome, which is important forfuture exploration of the etiology of depression and to
develop effective therapeutic strategies.Conflict of interest
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